Gene · 2921
Papers3,842
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,681 to 1,700 of 3,842
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CCL21 activation of the MALAT1/SRSF1/mTOR axis underpins the development of gastric carcinoma. | J Transl Med | 2021 | 34001131 | PubTator, text mining | PubMed |
| Single-cell transcriptome profiling reveals vascular endothelial cell heterogeneity in human skin. | Theranostics | 2021 | 33995668 | PubTator, text mining | PubMed |
| Innate Immune Cells in the Esophageal Tumor Microenvironment. | Front Immunol | 2021 | 33995371 | PubTator, text mining | PubMed |
| Tumor-associated macrophages in cholangiocarcinoma: complex interplay and potential therapeutic target. | EBioMedicine | 2021 | 33993051 | PubTator, text mining | PubMed |
| An integrated analysis of human myeloid cells identifies gaps in in vitro models of in vivo biology. | Stem Cell Reports | 2021 | 33989517 | PubTator, text mining | PubMed |
| Prostaglandin E3 attenuates macrophage-associated inflammation and prostate tumour growth by modulating polarization. | J Cell Mol Med | 2021 | 33982835 | PubTator, text mining | PubMed |
| The CD8+ T Cell Noncytotoxic Antiviral Responses. | Microbiol Mol Biol Rev | 2021 | 33980586 | PubTator, text mining | PubMed |
| Regulation and functional roles of chemokines in liver diseases. | Nat Rev Gastroenterol Hepatol | 2021 | 33976393 | PubTator, text mining | PubMed |
| Ubiquitin-specific peptidase 53 inhibits the occurrence and development of clear cell renal cell carcinoma through NF-κB pathway inactivation. | Cancer Med | 2021 | 33973730 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Reveals Tissue Compartment-Specific Plasticity of Mycosis Fungoides Tumor Cells. | Front Immunol | 2021 | 33968070 | PubTator, text mining | PubMed |
| METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection. | Cell Rep | 2021 | 33961823 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity. | Cancer Metastasis Rev | 2021 | 33959849 | PubTator, text mining | PubMed |
| CXCL1 Clone Evolution Induced by the HDAC Inhibitor Belinostat Might Be a Favorable Prognostic Indicator in Triple-Negative Breast Cancer. | Biomed Res Int | 2021 | 33959656 | PubTator, text mining | PubMed |
| Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer. | Nat Commun | 2021 | 33953163 | PubTator, text mining | PubMed |
| Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review. | Med Res Rev | 2021 | 33948974 | PubTator, text mining | PubMed |
| Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm. | Vaccines (Basel) | 2021 | 33946736 | PubTator, text mining | PubMed |
| Small molecule Y-320 stimulates ribosome biogenesis, protein synthesis, and aminoglycoside-induced premature termination codon readthrough. | PLoS Biol | 2021 | 33939688 | PubTator, text mining | PubMed |
| A Partial Picture of the Single-Cell Transcriptomics of Human IgA Nephropathy. | Front Immunol | 2021 | 33936064 | PubTator, text mining | PubMed |
| FABP4 deactivates NF-κB-IL1α pathway by ubiquitinating ATPB in tumor-associated macrophages and promotes neuroblastoma progression. | Clin Transl Med | 2021 | 33931964 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/papers?page=85